These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16601437)

  • 21. Transnasal endoscopic resection of juvenile nasopharyngeal angiofibroma without preoperative embolization.
    Borghei P; Baradaranfar MH; Borghei SH; Sokhandon F
    Ear Nose Throat J; 2006 Nov; 85(11):740-3, 746. PubMed ID: 17168151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Juvenile nasopharyngeal angiofibroma: an update of therapeutic management.
    Ungkanont K; Byers RM; Weber RS; Callender DL; Wolf PF; Goepfert H
    Head Neck; 1996; 18(1):60-6. PubMed ID: 8774923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoscopic assisted antral window approach for type III nasopharyngeal angiofibroma with infratemporal fossa extension.
    Khalifa MA; Ragab SM
    Int J Pediatr Otorhinolaryngol; 2008 Dec; 72(12):1855-60. PubMed ID: 18952302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
    Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
    Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical study of juvenile nasopharyngeal angiofibroma].
    Nong D; Tang A; Xu Z; Nong H; Liang Y; Wang D; Li Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Jan; 20(2):70-2. PubMed ID: 16570817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma.
    Wu SX; Chua DT; Deng ML; Zhao C; Li FY; Sham JS; Wang HY; Bao Y; Gao YH; Zeng ZF
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):761-9. PubMed ID: 17601682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Juvenile nasopharyngeal angiofibroma: clinical factors associated with recurrence, and proposal of a staging system.
    Carrillo JF; Maldonado F; Albores O; Ramírez-Ortega MC; Oñate-Ocaña LF
    J Surg Oncol; 2008 Aug; 98(2):75-80. PubMed ID: 18623038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment modalities of nasopharyngeal angiofibroma].
    Korcum AF; Ağirdir BV; Aksu G; Güney K; Dinç O
    Kulak Burun Bogaz Ihtis Derg; 2008; 18(4):263-7. PubMed ID: 19052499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Juvenile nasopharyngeal angiofibroma].
    Padilla Parrado M; Díaz Sastre MA; Jiménez Antolín JA; Caro García MA
    An Otorrinolaringol Ibero Am; 2005; 32(4):361-71. PubMed ID: 16156366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.
    Kong L; Lu JJ; Hu C; Guo X; Wu Y; Zhang Y
    Cancer; 2006 Sep; 107(6):1287-93. PubMed ID: 16909425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic vs. open surgery for treating large, locally advanced juvenile angiofibromas: a comparison of local control and morbidity outcomes.
    Bosraty H; Atef A; Aziz M
    Ear Nose Throat J; 2011 Nov; 90(11):529-34. PubMed ID: 22109921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Juvenile nasopharyngeal angiofibroma presenting as Foster Kennedy Syndrome.
    Aga A
    Ethiop Med J; 2001 Jul; 39(3):251-60. PubMed ID: 11921556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma.
    Saylam G; Yücel OT; Sungur A; Onerci M
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):227-34. PubMed ID: 16023739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definitive radiotherapy for nasopharyngeal carcinoma.
    Mendenhall WM; Morris CG; Hinerman RW; Malyapa RS; Amdur RJ
    Am J Clin Oncol; 2006 Dec; 29(6):622-7. PubMed ID: 17149001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Juvenile nasopharyngeal angiofibroma in a tertiary centre: ten-year experience.
    Tang IP; Shashinder S; Gopala Krishnan G; Narayanan P
    Singapore Med J; 2009 Mar; 50(3):261-4. PubMed ID: 19352568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical resection of type III juvenile angiofibroma without preoperative embolization.
    El-Banhawy OA; Ragab A; El-Sharnoby MM
    Int J Pediatr Otorhinolaryngol; 2006 Oct; 70(10):1715-23. PubMed ID: 16904759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformal radiotherapy in the treatment of advanced juvenile nasopharyngeal angiofibroma with intracranial extension: an institutional experience.
    Chakraborty S; Ghoshal S; Patil VM; Oinam AS; Sharma SC
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1398-404. PubMed ID: 20598454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endonasal endoscopic resection of juvenile nasopharyngeal angiofibroma.
    Eloy P; Watelet JB; Hatert AS; de Wispelaere J; Bertrand B
    Rhinology; 2007 Mar; 45(1):24-30. PubMed ID: 17432065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
    Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
    Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoradiotherapy for locally recurrent nasopharyngeal carcinoma: treatment outcome and prognostic factors.
    Nakamura T; Kodaira T; Tachibana H; Tomita N; Tomoda T; Nakahara R; Inokuchi H; Mizoguchi N; Takada A; Fuwa N
    Jpn J Clin Oncol; 2008 Dec; 38(12):803-9. PubMed ID: 18840881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.